Urologic Oncology: Seminars and Original Investigations
Volume 28, Issue 5 , Pages 473-479, September 2010

The epithelial-mesenchymal transition-inducing factor TWIST is an attractive target in advanced and/or metastatic bladder and prostate cancers☆

  • Hervé Wallerand, M.D., Ph.D.

      Affiliations

    • Department of Urology, Centre Hospitalo-Universitaire Pellegrin-Tripode, Victor Segalen School of Medicine, Bordeaux, France
    • Corresponding Author InformationCorresponding author. Tel.: +33-5-5679 5535; fax: +33-5-5679 5651
    • ,
  • Grégoire Robert, M.D.

      Affiliations

    • Department of Urology, Centre Hospitalo-Universitaire Pellegrin-Tripode, Victor Segalen School of Medicine, Bordeaux, France
    • ,
  • Gilles Pasticier, M.D.

      Affiliations

    • Department of Urology, Centre Hospitalo-Universitaire Pellegrin-Tripode, Victor Segalen School of Medicine, Bordeaux, France
    • ,
  • Alain Ravaud, M.D., Ph.D.

      Affiliations

    • Department of Medical Oncology, Centre Hospitalo-Universitaire Saint-André, Victor Segalen School of Medicine, Bordeaux, France
    • ,
  • Philippe Ballanger, M.D.

      Affiliations

    • Department of Urology, Centre Hospitalo-Universitaire Pellegrin-Tripode, Victor Segalen School of Medicine, Bordeaux, France
    • ,
  • Robert E. Reiter, M.D.

      Affiliations

    • Department of Urology, Jonsson Comprehensive Center, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA
    • ,
  • Jean-Marie Ferrière, M.D.

      Affiliations

    • Department of Urology, Centre Hospitalo-Universitaire Pellegrin-Tripode, Victor Segalen School of Medicine, Bordeaux, France

Received 13 November 2008; received in revised form 17 December 2008; accepted 18 December 2008. published online 09 March 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ This work was supported by a grant from Ligue Nationale contre le Cancer (LNCC).

PII: S1078-1439(08)00389-X

doi:10.1016/j.urolonc.2008.12.018

Urologic Oncology: Seminars and Original Investigations
Volume 28, Issue 5 , Pages 473-479, September 2010

Article Tools

* Image Usage & Resolution